Clinical applications of next generation sequencing on therapeutic decision-making in lung cancer

Clinical applications of next generation sequencing on therapeutic decision-making in lung cancer - Clinical applications of next generation sequencing on therapeutic decision-making in lung cancer

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000014782

Enrollment

100

Registered

2014-08-10

Start date

2013-07-05

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Lung cancer

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: (i) Histologically confirmed diagnosis of lung cancer (ii) patient provided written informed consent to conduct genomic studies in accordance with the Institutional Review Board of Kinki University.

Exclusion criteria

Exclusion criteria: None

Design outcomes

Primary

Measure	Time frame
We assessed the percentage of patients with additional therapy options uncovered by detecting potentially actionable genetic alterations.	—

Countries

Japan

Contacts

Public ContactMasayuki Takeda

Kinki University Medical oncology

takedamasa2004@yahoo.co.jp072-366-0221

Outcome results